Received July 27, 2022
Accepted January 30, 2023

Objectives: To assess the willingness of patients with infertility on continuing with their IVF treatment during the COVID-19 pandemic. Methods: This cross-sectional survey was conducted in the reproductive, endocrine, and infertility medicine department (REIMD) at [Information masked for peer review]. Patients that were planned to undergo IVF treatment at REIMD were contacted and asked about whether they would like to start IVF treatment during the COVID-19 pandemic from August 2020 to August 2021. Data was analyzed using SPSS version 24. Statistics obtained as means and standard deviations from continuous variables correlated with chi-square test and results were considered significant at P≤ 0.05. Results: Of the 400 participants, 245 (61.25%) were between the ages of 30- 39 years. About 42.75% (n=171) of patients had 6-10 years of infertility, and 18% (n=72) had at least one pregnancy but no living children. While 64.7% (n=259) of the participants responded from the first call, 83% (n=332) agreed to continue their treatment. Of those, 13% (n=43) preferred booking appointments as soon as possible, 29.8% (n=99) preferred booking within three months, while 57.2% (n=190) chose to book after three months. From our sample, 86.8% (n=59) were afraid to contract the virus and the choice to delay the IVF treatment correlated with the patient age (P< 0.001) and duration of infertility (P=0.007). Conclusion: The COVID-19 pandemic affected courses of IVF treatment, and many patients were afraid to be infected during it. However, most patients preferred to resume treatment despite possible risks and uncertainties.